BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 3493781)

  • 1. The interaction of antibody/DNA immune complexes with complement. Influence of antibody class and DNA conformation.
    Taylor RP; Edberg JC; Kujala GA; Sloman AJ; Wilson CC; Cronin ME
    Arthritis Rheum; 1987 Feb; 30(2):176-85. PubMed ID: 3493781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative determination of anti-dsDNA antibodies and antibody/dsDNA stoichiometries in prepared, soluble complement-fixing antibody/dsDNA immune complexes.
    Taylor RP; Horgan C
    Mol Immunol; 1984 Oct; 21(10):853-62. PubMed ID: 6334233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction between rheumatoid factor and antibody/DNA complexes: enhancement of complement fixation.
    Birchmore DA; Taylor RP; Waller SJ; Davis JS; Morley KW
    Arthritis Rheum; 1981 Mar; 24(3):527-33. PubMed ID: 7213431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement fixation by small, DNase-resistant DNA-anti-DNA immune complexes.
    Horgan C; Emlen W
    Mol Immunol; 1987 Feb; 24(2):109-16. PubMed ID: 3497335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The kinetics of [3H]-dsDNA/anti-DNA immune complex formation, binding by red blood cells, and release into serum: effect of DNA molecular weight and conditions of antibody excess.
    Horgan C; Burge J; Crawford L; Taylor RP
    J Immunol; 1984 Oct; 133(4):2079-84. PubMed ID: 6332147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative analyses of the binding of soluble complement-fixing antibody/dsDNA immune complexes to CR1 on human red blood cells.
    Edberg JC; Wright E; Taylor RP
    J Immunol; 1987 Dec; 139(11):3739-47. PubMed ID: 2960742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clearance kinetics and immunochemistry in rabbits of soluble antibody/DNA immune complexes. Effects of antibody class and DNA conformation.
    Edberg JC; Kujala GA; Taylor RP
    J Immunol; 1987 Jul; 139(1):180-7. PubMed ID: 3584985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamics of interaction between complement-fixing antibody/dsDNA immune complexes and erythrocytes. In vitro studies and potential general applications to clinical immune complex testing.
    Taylor RP; Horgan C; Hooper M; Burge J
    J Clin Invest; 1985 Jan; 75(1):102-11. PubMed ID: 3917462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased levels of anti-dsDNA antibodies in immune complexes before treatment with belimumab associate with clinical response in patients with systemic lupus erythematosus.
    Sohrabian A; Parodis I; Carlströmer-Berthén N; Frodlund M; Jönsen A; Zickert A; Sjöwall C; Bengtsson AA; Gunnarsson I; Rönnelid J
    Arthritis Res Ther; 2019 Nov; 21(1):259. PubMed ID: 31783909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lupus-derived human monoclonal IgM anti-DNA antibody displays monospecificity, high affinity and private idiotype specificity.
    Suenaga R; Abdou NI
    Lupus; 1992 Dec; 1(6):363-8. PubMed ID: 1304404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune complexes--pathogenetic factors of autoimmune systemic lupus erythematosus.
    Wollina U
    Allerg Immunol (Leipz); 1984; 30(1):3-13. PubMed ID: 6233860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stability of DNA/ANTI-DNA complexes. IV. Complement fixation.
    Pedersen SE; Taylor RP; Morley KW; Wright EL
    J Immunol Methods; 1980; 38(3-4):269-80. PubMed ID: 7440976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Binding of complement by anti-native desoxyribonucleic acid antibodies in systemic lupus erythematosus].
    Youinou P; Le Goff P; Jouquan J; Cledes J; Pennec Y; Mottier D; Abgrall JF; Tandé D; Cam P; Le Menn G
    Presse Med; 1985 Apr; 14(16):875-8. PubMed ID: 3158921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A kinetic study of erythrocyte-DNA/anti-DNA immune complex association and dissociation reactions in systemic lupus erythematosus.
    Meryhew NL; Westling PR; Eerdmans ME; Janecek EJ; Runquist OA
    Biochim Biophys Acta; 1989 Jun; 991(3):470-6. PubMed ID: 2786431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The fine specificity of IgG antiguanosine antibodies in systemic lupus erythematosus.
    Yee WS; Weisbart RH
    Clin Immunol Immunopathol; 1985 Aug; 36(2):161-7. PubMed ID: 3874031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A single-stranded DNA-cross-reactive immunogenic epitope of human homocysteine-inducible endoplasmic reticulum protein.
    Oka Y; Hirabayashi Y; Ikeda T; Fujii H; Ishii T; Harigae H
    Scand J Immunol; 2011 Sep; 74(3):296-303. PubMed ID: 21535081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of lupus disease by anti-double-stranded DNA antibodies of the IgM isotype in the (NZB x NZW)F1 mouse.
    Werwitzke S; Trick D; Kamino K; Matthias T; Kniesch K; Schlegelberger B; Schmidt RE; Witte T
    Arthritis Rheum; 2005 Nov; 52(11):3629-38. PubMed ID: 16255055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigen binding diversity of affinity purified autoantibodies against DNA.
    Ali A; Hasan R; Ali R
    Biochem Int; 1991 Jan; 23(1):111-8. PubMed ID: 1863265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IgM antibodies against dsDNA in SLE.
    Witte T
    Clin Rev Allergy Immunol; 2008 Jun; 34(3):345-7. PubMed ID: 18097774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clearance of anti-double-stranded DNA antibodies: the natural immune complex clearance mechanism.
    Craig ML; Bankovich AJ; McElhenny JL; Taylor RP
    Arthritis Rheum; 2000 Oct; 43(10):2265-75. PubMed ID: 11037886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.